Live news , top stories, corporate news, company news, sector news, economy news, results analysis news, ceo interviews, fund manager interview, advisor interview, market news, bazaar talk, hot stocks news, ipo news, commodities news, mutual fund news, insurance news, news wire
07 August, 2020 01:11 IST
USFDA bans drugs from 3 plants of Ipca Labs
Source: IRIS | 16 Jun, 2017, 12.19PM
Comments  |  Post Comment

Almost all drugs manufactured by Ipca Laboratories at its facilities at Pithampur, Silvassa and Ratlam have been banned from the US market by US Food and Drug Administration (USFDA).

The ban of all drugs will continue until the company can demonstrate that the drugs manufactured sites and intended for the US market are in compliance with Current Good Manufacturing Practice (CGMP).

Ipca Laboratories is engaged in manufacturing of active pharmaceutical ingredients and formulations. It operates in 110 countries and its export accounts for 50% of the company's income.

Shares of the company declined Rs 58.9, or 11.48%, to trade at Rs 454.25. The total volume of shares traded was 590,213 at the BSE (12.09 p.m., Friday).

Ipca Laboratories Limited   (Q,N,C,F)*

Comments Post comment 
 Post Comment
Name Email
Security Code type    into this box
Company Update
Home  |   Shares  |   F&O  |   Mutual Funds  |   Loans  |   Insurance  |   News Centre
Wealth Tracker  |   Newsletters  |   Tax Corner  |   NRI Centre  |   Advertise
© All rights reserved. IRIS Business Services Limited
A Disclaimer